NASDAQ:BPTH

Bio-path Holdings Stock Insider Trading

etoro logo Buy BPTH
*Your capital is at risk
$0.0300
+0.0066 (+28.21%)
At Close: Jun 03, 2026

Bio-Path Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.46M and sold 128.91K BPTH shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 2.46M shares
Sell 128.91K shares
96% Buy Activity
Strong Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 27, 2020
Buy
Common Stock Option (right to buy)
A-Award
Morris Douglas P
Director
Director 10 000
Value: $50.7K
Mar 27, 2020
Buy
Common Stock Option (right to buy)
A-Award
Cleaver Heath
Director
Director 10 000
Value: $50.7K
Mar 27, 2020
Buy
Common Stock Option (right to buy)
A-Award
Aubert Paul
Director
Director 10 000
Value: $50.7K
Mar 27, 2020
Buy
Common Stock Option (right to buy)
A-Award
Molsbergen Tamaro Martina
Director
Director 10 000
Value: $50.7K
Mar 18, 2020
Buy
Common Stock Option (right to buy)
A-Award
Nielsen Peter Henry
President, CEO & CFO
CEO / President 15 000
Value: $48.8K
Mar 18, 2020
Buy
Common Stock Option (right to buy)
A-Award
Nielsen Peter Henry
President, CEO & CFO
CEO / President 15 000
Value: $48.8K
Oct 11, 2019
Buy
Common Stock
J-Other
Molsbergen Tamaro Martina
Director 0
Value: $0
Oct 11, 2019
Buy
Common Stock
J-Other
Molsbergen Tamaro Martina
Director 0
Value: $0
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Cleaver Heath
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Morris Douglas P
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Nielsen Peter Henry
President, CEO & CFO
CEO / President 15 000
Value: $276.0K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Aubert Paul
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Colonnese Mark P
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Colonnese Mark P
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Aubert Paul
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Nielsen Peter Henry
President, CEO & CFO
CEO / President 15 000
Value: $276.0K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Morris Douglas P
Director
Director 1 000
Value: $18.4K
Mar 28, 2019
Buy
Common Stock Option (right to buy)
A-Award
Cleaver Heath
Director
Director 1 000
Value: $18.4K
Jan 18, 2019
Sell
Common Stock
S-Sale
Armistice Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Jan 18, 2019
Buy
Warrant
Armistice Capital, Llc
10 Percent Owner
10% Owner 96 878
Value: $0
Jan 18, 2019
Buy
Common Stock, par value $0.001 per share
Armistice Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Jan 18, 2019
Sell
Common Stock
S-Sale
Armistice Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Jan 18, 2019
Sell
Common Stock
S-Sale
Armistice Capital, Llc
10 Percent Owner
10% Owner 64 457
Value: $171.6K
Jan 18, 2019
Buy
Common Stock, par value $0.001 per share
Armistice Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Jan 18, 2019
Buy
Common Stock, par value $0.001 per share
Armistice Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIO-PATH HOLDINGS
Bio-Path Holdings
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE